The latest cancer drugs news
Browsing: Cancer Drug News
AI-driven study reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas
On November 19, 2025, the Food and Drug Administration approved selumetinib for adults with neurofibromatosis…
FDA approves epcoritamab-bysp for follicular lymphoma indications
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp with lenalidomide and rituximab for…
Much-needed new drug approved for acute myeloid leukaemia
Biomedical research that began at the University of Virginia School of Medicine, USA, has yielded…
New cancer drug shows exceptional tumour-fighting potential
A research team led by the Medical University of Vienna, the HUN-REN Research Centre for…
Abiraterone and enzalutamide show comparable outcomes in first-line metastatic hormone-sensitive prostate cancer
A retrospective cohort study of US veterans with metastatic hormone-sensitive prostate cancer (mHSPC) found no…
FDA approves imlunestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
On September 25, 2025, the Food and Drug Administration approved imlunestrant, an oestrogen receptor antagonist,…
FDA approves pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection
On September 19, 2025, the Food and Drug Administration approved pembrolizumab and berahyaluronidase alfa-pmph for…
FDA-approved MI cancer seek test enhances tumour profiling for precision oncology
A new research paper was published in Volume 16 of Oncotarget on August 13, 2025, titled “Clinical…